peroxynitrous acid has been researched along with rosiglitazone in 1 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (rosiglitazone) | Trials (rosiglitazone) | Recent Studies (post-2010) (rosiglitazone) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 4,749 | 556 | 1,818 |
| Protein | Taxonomy | peroxynitrous acid (IC50) | rosiglitazone (IC50) |
|---|---|---|---|
| CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1.1 | |
| Bile salt export pump | Homo sapiens (human) | 4.5853 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.069 | |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 0.08 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.56 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.832 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.2481 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.038 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.048 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.048 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.1 | |
| CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 2.29 | |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 0.731 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brookes, ZL; Huang, L; Nauli, SM; Ong, AC; Prasad, S; Ruff, L; Solanky, T; Upadhyay, VS | 1 |
1 other study(ies) available for peroxynitrous acid and rosiglitazone
| Article | Year |
|---|---|
Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.
Topics: Animals; Antioxidants; Arterioles; Calcium; Capillary Permeability; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Genotype; Heterozygote; Hypertension; Male; Mesentery; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Phenotype; Polycystic Kidney, Autosomal Dominant; PPAR gamma; Renal Insufficiency; Reperfusion Injury; Rosiglitazone; Superoxides; Thiazolidinediones; Time Factors; TRPP Cation Channels; Vasodilation; Vasodilator Agents; Venules | 2013 |